proposed research. These are important issues that should be addressed by the Environmental Genome Project. Issues such as these should be carefully considered and addressed during the early stage of the project. As noted at the beginning of the Environmental Genome Project symposium, the project is evolving and is a work in progress. As with any evolving program, it will continue to be molded by new ideas, information, and technologies.
The goal of the initial phase of the Environmental Genome Project is to stimulate research in the area of polymorphism discovery. This phase of the project does not specifically seek to assign polymorphism frequency. An allele has to be present only once in the repository to be discovered, yet accurately estimating the frequency of an allele in different ethnic groups requires genotyping of large numbers of individuals. Once polymorphisms (or alleles) have been discovered, study groups can be held to consider the research required for assignment of allele frequency. While the Environmental Genome Project does not seek to assign allele frequencies, we are aware of the importance of accurate allele frequency estimates for future epidemiologic studies and the large sample sizes such estimates will require. It is important to consider whether the sample size selected by the Environmental Genome Project will provide sufficient power to discover most alleles relevant to gene-environment interactions. Clearly, sampling 500 to 1,000 individuals will be adequate to identify many new polymorphisms. As pointed out during the symposium, sampling this number of individuals is adequate to identify most of the polymorphisms occurring commonly in the U.S. population. All of the newly identified polymorphisms will have the potential to be involved in gene-environment interactions, although none of them will be guaranteed to be so involved. It is also clear that various combinations of alleles may uniquely collaborate in environmentally associated disease. These allele combinations will, of course, be present in the population at lower levels than each allele alone. As As pointed out by Loffredo, Silbergeld, and Parascandola, another challenge to the Environmental Genome Project is in the area of its ethical, legal, and social implications. Symposium attendees discussed this topic in detail. These issues are complex and many-layered. It is highly unlikely that all the layers and nuances of the issues have been uncovered or that they will become simpler as the project evolves. To do justice to this component of the Environmental Genome Project, it is essential that sensitivity to these issues is upheld and that an effort is made to foster and maintain an open dialogue on these implications with both the scientific and nonscientific community.
One of the responsibilities faced by the Environmental Genome Project is to provide the science base upon which society can make better informed risk management decisions. We do not know nearly enough at the present time about how genetic susceptibility and environmental exposure collaborate in disease. The main goal of the Environmental Genome Project is to enhance population-based research toward identifying environmental exposure/disease relationships. As The reanalysis of global trends in reported human sperm counts by Swan et al. (1) concluded that a decline in sperm densities was observed in the United States and in Europe (1971 Europe ( -1990 but not in non-Western countries (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) . The report notes that recent studies from Europe and the United States indicate large interregional differences in sperm density. Interregional differences noted in the United States (New York City vs. Los Angeles, CA) were as large as the reported differences in mean sperm density in 1938 versus 1990.
Regional heterogeneity should alert us to be cautious in interpreting temporal trends in reported sperm densities for each region (2) . The only completely certain conclusion from the analysis of Swan et al. (1) is that there is a significant trend over time for sperm density studies to be reported from locations in the United States and Europe with lower sperm densities, while such a trend was not observed in reported studies from non-Western countries.
This limited conclusion is consistent with the data from single center studies where interregional differences are not a likely confounding factor. Single center studies in Europe report that sperm densities have declined over the last [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] years in Belgium (3), Finland (necropsy study) (4), London (area served by the Thames River water authority) (5), Paris (6) , and Scotland (7) but not in Denmark (8) , Finland (sperm count study) (9), London (outside area served by the Thames River water authority) (5), and Toulouse, France (10) . Single center studies in the United States have reported no decline in sperm counts over the last [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] plus years in Los Angeles (11), New York City (11, 12) , Roseville, Minnesota (11), Seattle, Washington (13) , and Wisconsin (14) .
Given the inherent limitations in analysis of retrospective studies, prospective studies of human sperm counts are needed to determine trends in semen quality and to identify possible causes where temporal trends are observed (15 (2) analyzed 61 papers covering five decades of data from multiple countries and found an overall decrease in sperm density. These data were subject to both geographic and temporal bias, as most of the studies in the initial decades of the study were conducted in New York and the majority of the reports were published after 1970. Obvious geographical differences could be the source of bias in the analysis as shown in the reanalysis of the Carlsen data by Fisch et al. (3) . Because we have no information regarding potential regional, racial, and/or ethnic variations in normal sperm count that may exist, it is impossible to ignore the potential impact of this type of confounder. If the earlier studies are excluded from the Carlsen interpretation, a second linear regression analysis detects no decline in sperm density (3) .
In a yet another reanalysis of the data obtained from Carlsen et al. (2) but using different statistical approaches, Olsen et al. (4) found that the data were robust enough to analyze only during the last 20 years, representing 88% of the total number of subjects. They found a lack of the diminishing tendency in all of their statistical models except the for the linear regression model proposed by Carlsen et al. (2. In this latest reanalysis of data, Swan et al.
(1) used a multiple regression analysis and stratified the information by geographic region. Although these authors made a very detailed analysis ofmany ofthe possible confounding factors (i.e., length of sexual abstinence, age, methods used to count sperm), it is difficult to rule them out definitively as having an impact on the results. There are significant methodological differences that could have influenced reported semen parameters, resulting in technical precision within an individual laboratory but significant interlaboratory variation. In the past, proficiency testing was not available for routine semen analysis. Thus, it is impossible to compare sperm counts obtained from different laboratories before standardization and quality control of the methodology was available. Statistical analysis of poor-quality data will always yield results with questionable significance. Another important factor is that even if a temporal sperm dedine was found in the United States and Europe by Swan et al. (1) , it is probable that the between-region variability may invalidate the condusions (i.e., early studies were predominantly from New York, a region with higher sperm counts).
Other studies in specific geographic locations have only enhanced the controversy with a decline in sperm count detected in certain specific areas of the world [Finland (5), London (6), Belgium (7),
